Xarelto (Cardinal Health)
Welcome to the PulseAid listing for the Xarelto drug offered from Cardinal Health. This Factor Xa Inhibitors [MoA],Factor Xa Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cardinal Health |
| NON-PROPRIETARY NAME: | rivaroxaban |
| SUBSTANCE NAME: | RIVAROXABAN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Factor Xa Inhibitors [MoA],Factor Xa Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-07-01 |
| END MARKETING DATE: | 0000-00-00 |
Xarelto HUMAN PRESCRIPTION DRUG Details:
| Item Description | Xarelto from Cardinal Health |
| LABELER NAME: | Cardinal Health |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 2011-07-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 55154-1422_cb8f73ea-f8b1-4c94-a7f0-bf7bbd655b64 |
| PRODUCT NDC: | 55154-1422 |
| APPLICATION NUMBER: | NDA022406 |
Other RIVAROXABAN Pharmaceutical Manufacturers / Labelers:
